Pulmonary Hypertension Associated with Left-Sided Heart Disease - 09/08/11
Doi : 10.1016/j.ccm.2006.12.001
Ronald J. Oudiz, MD a, b, ⁎ 
a David Geffen School of Medicine at UCLA, CA, USA
b Department of Medicine, Division of Cardiology, Liu Center for Pulmonary Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, #405, Torrance, CA 90502-2006, USA
Department of Cardiology, Liu Center for Pulmonary Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, 1124 West Carson Street, #405, Torrance, CA 90502-2006.Abstract |
Pulmonary hypertension (PH) denotes a poor prognosis in patients with left-sided heart disease. No study has demonstrated long-term benefit from PH drugs such as prostanoids, endothelin antagonists, and phosphodiesterase-5 inhibitors. In some cases, cautious use of PH drugs may be indicated. However, theoretic and practical concerns limit any formal recommendations.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 28 - N° 1
P. 233-241 - mars 2007 Retour au numéro
Article précédent
- Pulmonary Hypertension Associated with Chronic Respiratory Disease
- Reda E. Girgis, Stephen C. Mathai
- Congenital Heart Disease Associated Pulmonary Arterial Hypertension
- Michael J. Landzberg
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?